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Summary
Resistance to high concentrations of bile salts in the
human intestinal tract is vital for the survival of
enteric bacteria such as Escherichia coli. Although
the tripartite AcrAB–TolC efflux system plays a sig-
nificant role in this resistance, it is purported that
other efflux pumps must also be involved. We provide
evidence from a comprehensive suite of experiments
performed at two different pH values (7.2 and 6.0) that
reflect pH conditions that E. coli may encounter in
human gut that MdtM, a single-component multidrug
resistance transporter of the major facilitator super-
family, functions in bile salt resistance in E. coli by
catalysing secondary active transport of bile salts out
of the cell cytoplasm. Furthermore, assays performed
on a chromosomal ΔacrB mutant transformed with
multicopy plasmid encoding MdtM suggested a func-
tional synergism between the single-component
MdtM transporter and the tripartite AcrAB–TolC
system that results in a multiplicative effect on resist-
ance. Substrate binding experiments performed on
purified MdtM demonstrated that the transporter
binds to cholate and deoxycholate with micromolar
affinity, and transport assays performed on inverted
vesicles confirmed the capacity of MdtM to catalyse
electrogenic bile salt/H+ antiport.
Introduction
The mammalian intestine is a complex, densely populated
microbial ecosystem that is home to hundreds of different
species and strains of bacteria (Ley et al., 2006; Qin et al.,
2010; De Paepe et al., 2011). To survive and proliferate in,
for example, the human gastrointestinal tract, the enteric
bacterium Escherichia coli has evolved not only to resist
the acidic environment of the duodenum but also the
antimicrobial effects of up to 30 mM concentrations of bile
salts and their free acids (Thanassi et al., 1997; Kalantzi
et al., 2006; Merritt and Donaldson, 2009; Darkoh et al.,
2010). Bile salts are amphipathic, water-soluble, steroidal
surfactants, synthesized in the liver from cholesterol and
secreted into the bile, that aid emulsification and enzy-
matic digestion of dietary lipids in the small intestine
(Maldonado-Valderrama et al., 2011). In humans, bile
acids are secreted from hepatocytes as salts, in a form
conjugated, via an amide bond, to glycine or taurine
(Maldonado-Valderrama et al., 2011). Although the major-
ity of these bile salts are reabsorbed by the lining of the
ileum for subsequent reuse, those that remain are decon-
jugated by bacterial enzymes to form free primary bile
acids such as cholate (Hofmann, 1999; Ridlon et al.,
2006). Further reactions, again catalysed by intestinal
flora enzymes, transform the primary bile acids into the
secondary bile acids deoxycholate (DOC) and lithocho-
late (Hylemon et al., 1991; Hofmann, 1999; Ridlon et al.,
2006); the latter is rapidly eliminated from the body and
constitutes only trace amounts of the unconjugated biliary
bile acids, the remainder being about equal amounts of
cholate, chenodeoxycholate and deoxycholate (Hofmann,
1999).
Over the physiological pH range encountered in the
small intestine, conjugated bile salts are fully ionized, and
are therefore present as strongly acidic bile acid anions
(Hofmann, 1999) that require the OmpF porin in order to
traverse the outer membrane of Gram-negative bacteria
(Thanassi et al., 1997). In contrast, the unconjugated bile
salts are weakly acidic molecules that, in their uncharged,
protonated state, can diffuse across both the outer and
inner membranes of Gram-negative bacteria to accumu-
late in the cell cytoplasm from where they exert their
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cytotoxic effects by way of disruption of cell membrane
integrity, promotion of RNA secondary structure formation,
DNA damage, denaturation of cellular proteins, and oxi-
dative stress (Merritt and Donaldson, 2009). Therefore,
E. coli and other enteric bacteria must possess mecha-
nisms to defend against these types of injury. The main
defensive mechanism employed by Gram-negative bac-
teria is the active extrusion of bile salts and their deriva-
tives from the interior of the cell by multidrug resistance
efflux systems (Gunn, 2000). Intrinsic resistance to bile
salts in E. coli is conferred in part by the constitutively
expressed resistance-nodulation-division (RND)-type and
major facilitator superfamily (MFS)-type tripartite AcrAB–
TolC and EmrAB–TolC multidrug efflux systems respec-
tively (Ma et al., 1995; Fralick, 1996; Thanassi et al.,
1997). More minor contributions are provided by YdhE of
the multidrug and toxic compound extrusion (MATE)
family, and the YdgEF small multidrug resistance (SMR)
protein (Nishino and Yamaguchi, 2001). However, it has
been posited that an additional, unidentified efflux system,
probably a proton antiporter, also plays a significant role in
protecting E. coli from the noxious effects of bile salts
(Thanassi et al., 1997).
Apart from those proteins already confirmed as playing
a role in bile salt efflux, the E. coli ‘effluxome’ contains 33
other putative multidrug transporters that, considering the
broad catalogue of chemically and structurally dissimilar
substrates they can handle, are candidates to function in
this role (Nishino and Yamaguchi, 2001). Our previous
work on one of these transporters, MdtM, suggested it
might possess capacity to function physiologically in
removal of bile salts from the cell (Holdsworth and
Law, 2012a,b). MdtM is a single-component, 12
transmembrane-spanning drug/H+ antiporter of the DHA1
subfamily of the MFS (Holdsworth and Law, 2012a) that is
energized by components of the transmembrane electro-
chemical gradient (Holdsworth and Law, 2013). MdtM is
extremely versatile with respect to function; apart from its
role as a multidrug transporter that can efflux several
classes of antibiotic and a variety of quaternary ammo-
nium compounds from the cell cytoplasm (Edgar and Bibi,
1997; Nishino and Yamaguchi, 2001; Tal and Schuldiner,
2009; Soo et al., 2011; Holdsworth and Law, 2012a,b), it
also possesses a Na+(K+)/H+ antiport activity that enables
it to function in alkaline pH homeostasis in E. coli
(Holdsworth and Law, 2013). Although a putative Eubac-
terium MFS transporter, BaiG, has been implicated in the
uptake of bile acids (Mallonee and Hylemon, 1996), a role
for single-component transporters of the MFS in their
efflux has not been reported. We performed growth inhi-
bition studies, transport assays with inverted membrane
vesicles, and substrate binding studies using purified
protein to investigate if MdtM confers E. coli with resist-
ance against the harmful effects of cholate and deoxycho-
late (Doerner et al., 1997) at two different physiologically
relevant pH values: (i) at a pH of 7.2 that reflects the pH
of the colon (McDougall et al., 1993), and (ii) at a pH of 6.0
that reflects the acidic pH of the duodenum (Rune and
Viskum, 1969). Taken together, the results of our experi-
ments support MdtM as part of the efflux network that
protects E. coli from bile salt stress; this activity likely
represents a natural physiological role of the protein
(Neyfakh, 1997; Piddock, 2006).
Results
Bile salt resistance in E. coli is aided by mdtM
To test for a contribution by the mdtM gene product to bile
salt resistance in E. coli, the growth of wild-type E. coli
BW25113 and its isogenic ΔmdtM mutant under cholate
and deoxycholate stress was investigated by measuring
the minimum inhibitory concentration (MIC) of each bile
salt (Table 1). The BW25113 strain of E. coli was chosen
for this aspect of the study as it contains a full complement
of multidrug efflux proteins and has been used before for
investigations into MdtM function (Tal and Schuldiner,
2009; Holdsworth and Law, 2012a,b; 2013). MICs of
cholate and deoxycholate for E. coli BW25113 single-
deletion mutants that are dysfunctional with respect to
tripartite EmrAB–TolC and AcrAB–TolC efflux activity were
also determined to permit a comparison of the contribu-
tion of each of those transporters to bile salt resistance.
Additionally, the effect of deleting the outer membrane
porin ompF in the BW25113 strain was tested.
As shown in Table 1, deletion of mdtM resulted in a
phenotype that was twofold more susceptible to cholate
and fourfold more susceptible to deoxycholate than wild-
type E. coli BW25113. Not surprisingly, considering the
especially significant role of the tripartite efflux system
AcrAB–TolC in bile salt resistance in E. coli (Ma et al.,
1995; Thanassi et al., 1997), deletion of chromosomal
acrB resulted in a bile salt-hypersensitive phenotype with
cholate and deoxycholate MICs decreased from 128 to
8 mg ml−1 and from 128 to < 1 mg ml−1 respectively. The
difference in sensitivity to each bile salt is a consequence
Table 1. MICs of cholate and deoxycholate in isogenic strains of
E. coli BW25113.
Strain
MIC (mg ml−1) of
Na+ cholate Na+ deoxycholate
Wild-type 128 128
ΔmdtM 64 32
ΔacrB 8 < 1
ΔemrB 128 64
ΔompF 128 128
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of their hydrophobicity (which is highest for deoxycholate),
and hence, with the ability of each to diffuse across the
bacterial membrane system and into the cell cytoplasm
(Kamp et al., 1993). The ability of the unconjugated bile
salts to diffuse freely across the bacterial membranes was
further illustrated by the MICs determined in the ΔompF
mutant; deletion of OmpF porin in the BW25113 strain had
no effect on bile salt resistance.
In contrast to the dramatic effect that deletion of chro-
mosomal acrB had on bile salt resistance, the absence of
a functional MFS-type EmrAB–TolC tripartite efflux
system had negligible effect on cholate resistance, and
resistance to deoxycholate decreased only twofold. The
apparent lack of protection against cholate by a system
that reportedly plays a significant role in bile salt resist-
ance (Thanassi et al., 1997; Li and Nikaido, 2004) is not
unexpected because the AcrAB–TolC and EmrAB–TolC
tripartite pumps work in parallel and not in series, and
therefore their effect is additive and not multiplicative (Lee
et al., 2000). As such, the contribution of EmrAB–TolC is
much smaller as compared to AcrAB–TolC and the effect
of emrB deletion is seen only in the background of dys-
functional AcrAB–TolC (Thanassi et al., 1997).
The MIC determinations suggest that, although not
essential, the mdtM gene product makes a significant
contribution to both cholate and deoxycholate resistance
in E. coli. Analysis of mdtM transcript levels revealed that
they are not upregulated upon bile salt challenge and that
there was no statistically significant change in mdtM tran-
scription between cholate-treated versus untreated
control E. coli, relative to a 16S rRNA reference (data not
shown). This implies that the ‘housekeeping’ levels of
MdtM present in the membrane at the onset of bile
salt challenge are sufficient to contribute effectively to
resistance.
Expression of plasmidic mdtM recovers a bile
salt-resistant phenotype
To test further the contribution of mdtM to bile salt resist-
ance, ΔmdtM cells were transformed with an arabinose-
inducible multicopy plasmid (pMdtM) that encoded wild-
type MdtM, and the ability of overexpressed transporter to
protect cells from the cytotoxic effects of cholate and
deoxycholate was determined by growth inhibition assays
that measured the concentration of bile salt required to
inhibit cell growth by 50% of that measured in the absence
of the substrate (the IC50 value) (Soothill et al., 1992).
ΔmdtM cells that overproduced dysfunctional MdtM from
the pD22A plasmid acted as a control (Holdsworth and
Law, 2012a). Assays were performed in LB liquid media
buffered to two different pH values (7.2 and 6.0) that
mirror the pH conditions experienced by enteric bacteria
as they negotiate the mammalian intestine (Rune and
Viskum, 1969; McDougall et al., 1993).
As shown in Fig. 1A–D, deletion of chromosomal mdtM
resulted in a phenotype that was clearly more susceptible
to bile salts than wild-type cells. The data also revealed
Fig. 1. Susceptibility of E. coli BW25113 wild-type cells and ΔmdtM single-deletion mutant, and ΔmdtM and ΔacrB single-deletion mutants
transformed with pMdtM or pD22A to bile salts.
A–D. IC50 measurements revealed that transformation of E. coli BW25113 ΔmdtM cells with plasmidic mdtM enhanced bile salt resistance. IC50
of (A) cholate at pH 7.2; (B) deoxycholate at pH 7.2; (C) cholate at pH 6.0; (D) deoxycholate at pH 6.0.
E–H. The ΔacrB chromosomal deletion mutant that overexpressed dysfunctional MdtM D22A mutant was hypersensitive to bile salts. IC50 of
(E) cholate at pH 7.2; (F) deoxycholate at pH 7.2; (G) cholate at pH 6.0; (H) deoxycholate at pH 6.0.
Bars and error bars represent the mean ± SD of three separate experiments. **Significant at P < 0.01; ***significant at P < 0.001; ****significant
at P < 0.0001.
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the BW25113 strain of E. coli to be less resistant to deoxy-
cholate than to cholate; at the slightly alkaline pH of 7.2,
the IC50 value of wild-type BW25113 for cholate was
35.6 ± 1.8 mM, whereas an IC50 of 28.2 ± 1.2 mM was
calculated for the same cell type grown in the presence of
deoxycholate (Fig. 1A and B); these IC50 values are about
threefold and fourfold greater, respectively, than the IC50
values (14.6 ± 3.6 mM for cholate, and 7.5 ± 1.1 mM for
deoxycholate) calculated for ΔmdtM single-deletion
mutant cells grown under the same conditions. However,
complementation of ΔmdtM cells with plasmidic mdtM
(pMdtM) recovered a phenotype with greater than wild-
type levels of resistance to each bile salt. In contrast,
ΔmdtM control cells that overexpressed dysfunctional
MdtM D22A mutant transporter from a multicopy plasmid
(pD22A) displayed no resurrection of bile-salt resistance.
Comparison of the IC50 data also revealed that suscep-
tibility of wild-type cells to both bile salts was enhanced at
acidic pH, with IC50 values of 22.3 ± 1.1 mM and
18.4 ± 1.6 mM for cholate and deoxycholate, respectively,
for cells grown at pH 6.0 (Fig. 1C and D). The IC50 values
of the ΔmdtM mutant cells and those that overexpressed
dysfunctional MdtM at this pH, however, were very similar
to those calculated for the same cells grown at pH 7.2.
Again, overexpression by ΔmdtM cells of functional MdtM
from a multicopy plasmid rescued a bile salt-resistant
phenotype. In all cases, statistical analysis of the IC50 data
using a two-tailed Student’s t-test confirmed that the dif-
ferences in susceptibility observed between wild-type and
ΔmdtM mutant cells to the bile salts under test were
significant (P < 0.05). Western blot analysis of dodecyl-β-
D-maltopyranoside (DDM) detergent-solubilized cytoplas-
mic membranes from ΔmdtM cells transformed with
pMdtM or pD22A provided evidence that the observed
differences in susceptibility to the bile salts did not origi-
nate from differences in the expression of recombinant
transporter; the levels of wild-type MdtM and dysfunc-
tional D22A protein production in the ΔmdtM transfor-
mants grown at pH 7.2 and pH 6.0 were similar
(Fig. S1A).
MdtM acts synergistically with AcrAB–TolC to efflux
bile salts
Evidence suggests that single-component membrane
transporters can interact synergistically with tripartite
RND-type proteins to form a dual-stage efflux mechanism
that provides multiplicative effects on drug resistance
(Lee et al., 2000). To test if interplay between MdtM and
AcrAB–TolC holds for efflux of bile salts, and also if MdtM
is capable of functioning unilaterally in bile salt efflux, we
performed growth assays that measured the IC50 of
cholate and deoxycholate for BW25113 ΔacrB cells trans-
formed with plasmidic DNA encoding wild-type MdtM or,
as a control, the dysfunctional D22A mutant (Fig. 1E–H).
Levels of overproduction of wild-type and mutant MdtM
protein were similar at both pH values investigated, as
determined by Western blot analysis (Fig. S1B).
Absence of functional AcrAB–TolC and MdtM efflux
systems resulted in cells that were hypersensitive to the
cytotoxic effects of each bile salt, with IC50 values that
were at least an order of magnitude smaller than the IC50s
of wild-type cells (Fig. 1E–H). Complementation of ΔacrB
cells with pMdtM recovered a phenotype that was less
susceptible; at pH 7.2, the IC50 values of these cells for
cholate and deoxycholate were 12.5 ± 2.1 mM and
9.7 ± 1.2 mM, respectively (Fig. 1E and F), and at pH 6.0
the corresponding IC50 values were 8.7 ± 0.9 mM and
6.8 ± 0.9 mM (Fig. 1G and H). Although these IC50 values
were approximately four- to fivefold greater than those of
the ΔacrB mutant transformed with pD22A (Fig. 1E–H),
they were similar to those measured for the chromosomal
mdtM-deletion mutant under the same conditions
(Fig. 1A–D). The inability of ΔacrB cells that overproduced
MdtM to recover the levels of cholate and deoxycholate
resistance observed in wild-type cells highlights the major
role in efflux played by AcrAB–TolC and suggests that,
even though MdtM clearly possesses capacity to function
independently in bile salt resistance, a functional syner-
gism between MdtM and AcrAB–TolC provides greater
levels of resistance.
Bile salts compete with other antimicrobials for
MdtM-mediated efflux
Although the results of growth inhibition assays implicated
the mdtM gene product in protecting cells from bile salt
cytotoxicity, they did not provide any direct evidence that
MdtM mediates bile salt efflux. To provide initial confirma-
tion of this, the effect of the addition of sodium cholate and
sodium deoxycholate on the ethidium bromide (EtBr)
efflux activity of MdtM was measured by whole-cell fluo-
rescence assays that used E. coli UTL2 outer permeabil-
ity mutant cells transformed with plasmidic MdtM. These
assays were performed at pH 6.0 to abrogate any poten-
tial interference by the electrogenic Na+/H+ antiport activity
of MdtM that is apparent at pH values > 7.0 (Holdsworth
and Law, 2013).
In the positive control assay, performed in a buffer
system that contained no added bile salt, addition of
glucose to energize cells that expressed wild-type MdtM
resulted in a rapid decrease in the fluorescence signal as
the transporter actively extruded EtBr from the cell
against its concentration gradient (Fig. 2, trace A). Sub-
sequent addition of the ionophore carbonyl cyanide
3-chlorophenylhydrazone (CCCP) caused the fluores-
cence signal to rise again, indicating that the observed
EtBr efflux was driven by the electrochemical gradient.
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Negative control cells that expressed dysfunctional MdtM
D22A mutant from a multicopy plasmid were incapable of
mediating any significant EtBr efflux (Fig. 2, trace E). To
ensure that any observed inhibition of EtBr efflux was not
due to competition by the sodium counterions of each
added bile salt, transport experiments were performed
with 3.0 mM NaCl added to the system (Fig. 2, trace B).
Incubation of cells that overexpressed wild-type MdtM
with sodium cholate or sodium deoxycholate at a final
concentration of 3.0 mM prior to addition of glucose
caused a dramatic decrease in the magnitude of the
observed fluorescence signal that was indicative of inhi-
bition of MdtM-mediated EtBr efflux by the bile salts
(Fig. 2, traces C and D respectively). Subsequent col-
lapse of the membrane potential by addition of CCCP
resulted in a dequench of the fluorescence signal and
suggested that detergent activity of the bile salts had
not compromised inner membrane integrity. When
re-energized, the same cells retained capacity to efflux
EtBr (Fig. S2), adding further support to our contention
that the reduction in EtBr transport activity observed in
bile salt-treated cells was due to competition between the
different substrates for MdtM and not due to perturbation
of the cell membrane. In contrast, the effects of mem-
brane disruption on EtBr transport were readily apparent
from the results of control assays performed on cells
treated with DDM detergent, a non-substrate of MdtM. In
this case, addition of DDM to the assay mixture resulted in
an immediate rise in the fluorescence signal as EtBr
leaked back into the cell through the detergent-
compromised membrane (Fig. S2).
MdtM binds cholate and deoxycholate at
micromolar concentrations
To confirm that MdtM was capable of binding bile salts,
the binding of cholate and deoxycholate to purified trans-
porter in dodecyl-β-D-maltoside (DDM) detergent solution
at pH 6.0 and pH 7.2 was determined using intrinsic tryp-
tophan (Trp) fluorescence with excitation at 295 nm.
Sequential addition of bile salt aliquots to purified protein
in DDM solution resulted in a concentration-dependent
quenching of the Trp fluorescence emission signal without
shifting the λmax at 335 nm, suggesting that the quench
resulted from a specific interaction between bile salt and
the MdtM substrate-binding pocket, and that one or more
Trp residues acted as reporters for binding. Threading of
the MdtM primary sequence onto the 3-D crystal structure
of the closely related E. coli MFS multidrug transporter
EmrD (Yin et al., 2006) proposed only one of the nine Trp
residues of MdtM, Trp309, as being located near the
putative binding pocket of the transporter and, therefore,
likely to be involved in the bile salt-induced quenching.
Fluorescence measurements performed on Trp309Phe
(W309F) and Trp309Ala (W309A) MdtM mutants sup-
ported this contention, with quenching induced by bile salt
in both mutants severely reduced compared to that of the
wild-type transporter and due probably to a non-specific
interaction with the protein (Fig. S3).
Analysis of the binding data revealed that MdtM pos-
sessed micromolar affinity for the bile salts. The protein
displayed greater affinity for cholate than deoxycholate
and, as pH decreased, there was a concomitant decrease
in binding affinity (Fig. 3). There was also a substrate- and
pH-dependent variability in the magnitude of the Trp fluo-
rescence quench, which ranged from about 25% in the
presence of cholate at pH 7.2 (Fig. 3A) to about 12% in
the presence of deoxycholate at pH 6.0 (Fig. 3D). At
pH 7.2, the apparent dissociation constant (Kdapp) of MdtM
for cholate was 24 ± 6 μM (Fig. 3A), whereas the protein
appeared to bind deoxycholate about sevenfold less tight
with a Kdapp of 176 ± 20 μM (Fig. 3B). Acidic pH decreased
the affinity of MdtM for both bile salts; at pH 6.0 the Kdapp
Fig. 2. Whole-cell ethidium bromide transport assays. Both
cholate and deoxycholate inhibited MdtM-mediated ethidium
bromide (EtBr) efflux from E. coli UTL2 cells expressing
recombinant wild-type MdtM. Traces represent EtBr efflux (A) in the
absence of bile salt; (B) in the presence of 3 mM Na+; (C) in the
presence of 3 mM sodium cholate; and (D) in the presence of
3 mM sodium deoxycholate. (E) A negative control was provided by
UTL2 cells that expressed the dysfunctional MdtM D22A mutant.
After 90 s in the fluorometer, cells loaded with EtBr were energized
by addition of glucose (first arrow) and efflux of EtBr was monitored
for a further 450 s. At this point, 100 μM CCCP was added as
indicated (second arrow) to abolish active transport and the
fluorescence emission was monitored for a further 260 s. All assays
were performed at pH 6.0. Fluorescence intensity was measured in
counts per second (cps).
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values for cholate and deoxycholate were 52 ± 5 μM
(Fig. 3C) and 227 ± 4 μM (Fig. 3D) respectively. To
ensure the observed increase in Kdapp at acidic pH was not
due to loss of structural integrity of the protein, the CD
spectrum of purified transporter in DDM detergent solu-
tion at pH 6.0 and pH 7.2 was measured. Figure S4 illus-
trates the similarity in the CD spectra of MdtM at both
pH values. The spectra are superimposable down to
∼ 196 nm, suggesting that there were no gross structural
changes in the secondary structure of the protein follow-
ing the change in pH. Below 196 nm there was a slight
(< 10%) decrease in ellipticity in the spectrum of the trans-
porter at the acidic pH (Fig. S4, black trace). The second-
ary structure estimates at each pH, however, were in
close agreement (Table 2).
MdtM mediates a bile salt/H+ exchange driven by the
electrochemical gradient
The binding affinity assays revealed that MdtM is capable
of binding cholate and deoxycholate. However, evidence
of binding cannot be construed as evidence of subse-
quent efflux. To show experimentally that MdtM can
actively mediate bile salt/H+ antiport across the cytoplas-
mic membrane, transport assays on inverted membrane
vesicles generated from antiporter-deficient E. coli TO114
cells that overproduced wild-type transporter were per-
formed by measuring the fluorescence dequenching of
the pH-sensitive fluorophore acridine orange upon addi-
tion of bile salts to the assay mixture (Figs 4 and S5). The
presence of RND-type efflux proteins in the TO114 cells
was not a confounding factor in the assays because those
particular transporters are rendered dysfunctional during
vesicle production, probably due to disruption of their
Fig. 3. Substrate binding assays. Substrate-binding affinity curves showing percentage intrinsic fluorescence quenching of purified wild-type
MdtM in DDM solution as a function of bile salt concentration. Binding affinity of (A) sodium cholate and (B) sodium deoxycholate for MdtM at
pH 7.2, and (C) sodium cholate and (D) sodium deoxycholate for MdtM at pH 6.0. Curves were fitted using SigmaPlot 10. Data points and
error bars represent the mean ± SD of three individual measurements.
Table 2. Secondary structure content of detergent-solubilized MdtM
at pH 7.2 and pH 6.0.
pH % α-helices % β-sheets % turns % unknown
6.0 52.4 9.5 14.8 23.3
7.2 53.9 10.4 12.8 22.9
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quaternary structure (Thanassi et al., 1997). A series of
initial experiments (data not shown) were performed to
determine the concentration of each bile salt that gave the
optimal fluorescence dequench signal; these concentra-
tions were found to be 2.5 mM and 2.0 mM for sodium
cholate and sodium deoxycholate respectively. Control
experiments with vesicles containing the MdtM D22A
mutant (Fig. 4B, D and F; Fig. S5B, D and F) support our
argument that the fluorescence dequench measured in
vesicles enriched with wild-type MdtM was specific to that
transporter activity and not due to action of the bile salts
on the vesicular membrane.
In assays performed at pH 7.2 (Fig. 4) addition of
D-lactate to energize the vesicle membranes caused a
rapid quench of the acridine orange fluorescence signal
as protons were pumped by respiratory chain proteins into
the vesicular lumen to generate a ΔpH (acid inside). Addi-
tion of bile salt to inverted vesicles enriched with recom-
binant wild-type MdtM resulted in a rapid dequenching of
the acridine orange steady-state fluorescence (Fig. 4A
and C). The observed dequench of the acridine orange
fluorescence signal originated from alkalinization of the
vesicular lumen as protons were pumped out to drive
active uptake of the added bile salt, thus implying that
MdtM was responsible for catalysing both cholate/H+ and
deoxycholate/H+ exchange reactions. Support for the con-
tention that the observed dequench was due exclusively
to MdtM-mediated bile salt/H+ antiport came from assays
performed on control vesicles generated from cells that
overexpressed the dysfunctional MdtM D22A mutant
(Fig. 4B and D). In these assays, addition of 2.0 mM
sodium deoxycholate to the vesicles at the time indicated
had no effect on the fluorescence signal (Fig. 4D). Addi-
tion of 2.5 mM sodium cholate to the same control vesi-
cles, however, resulted in small but reproducible
dequench of the fluorescence (Fig. 4B) that probably
originates from the activity of chromosomally encoded
MdtM, or from other transporters that possess cholate
transport activity under the experimental conditions
employed and whose role in cholate efflux is not yet
described. Assays performed at pH 6.0 (Fig. S5) gave
similar results to those performed at pH 7.2, except that
the magnitude of the fluorescence dequench upon addi-
tion of bile salt was more pronounced in assays per-
formed at the latter pH value.
In all the assays performed, addition of the uncoupler
CCCP resulted in complete dissipation of the ΔpH across
the vesicle membrane, as revealed by an instantaneous
and essentially maximal dequenching of the fluorescence
signal; this not only validated the assertion that the initial
fluorescence dequench observed upon the addition of the
bile salts was due to MdtM-catalysed bile salt/H+
exchange activity driven by the electrochemical gradient,
but also confirmed that the inverted vesicles remained
intact and maintained integrity throughout the life of the
assays.
MdtM possesses an Na+/H+ antiport activity that is
readily apparent at alkaline pH values, and this activity
competes with the multidrug efflux role of the transporter
(Holdsworth and Law, 2013). MIC measurements per-
formed at pH 8.5 suggested that the same Na+/H+ antiport
activity effectively inhibited the bile salt efflux function of
MdtM (Table S1). Therefore, to exclude MdtM-mediated
Na+/H+ exchange as a source of the acridine orange fluo-
rescence dequench that occurred upon addition of the
sodium salts of cholate and deoxycholate to the inverted
Fig. 4. MdtM-dependent bile salt/H+ exchange in inverted vesicles
at pH 7.2.
Measurements of ΔpH were performed by monitoring the
fluorescence quench/dequench of acridine orange upon addition of
bile salts to inverted vesicles of E. coli TO114 cells that
overproduced recombinant wild-type MdtM (left-hand trace of each
panel) or, as a control, the dysfunctional D22A mutant (right-hand
trace of each panel). Sodium cholate (A and B) or sodium
deoxycholate (C and D) at final concentrations of 2.5 mM and
2 mM, respectively, was added to vesicles as indicated to initiate
the transport reaction. Additional control assays were performed by
the addition of sodium gluconate (Na+) to the inverted vesicles (E
and F). Respiration-dependent generation of ΔpH (acid inside) was
established by addition of lactate to 2 mM, and CCCP at a final
concentration of 100 μM was used to dissipate ΔpH. The traces are
representative of experiments performed in triplicate on at least two
separate preparations of inverted vesicles. The fluorescence scale
(50% Q) represents 50% of the initial acridine orange fluorescence
signal prior to addition of lactate.
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vesicles, a further set of control assays was performed. In
these assays, again performed at pH 7.2 (Fig. 4E and F)
and pH 6.0 (Fig. S5E and F), 2.5 mM sodium gluconate
was added at the time indicated to lactate-energized
inverted vesicles produced from TO114 cells that overex-
pressed wild-type MdtM, or its dysfunctional D22A
mutant, from plasmidic DNA. There was no measureable
dequench of the respiration-induced acridine orange fluo-
rescence quench in response to added sodium in both the
test and control vesicles at pH 6.0 (Fig. S5E and F).
However, at pH 7.2, addition of the monovalent cation to
vesicles containing wild-type MdtM caused a small
dequench (< 20% of that observed in vesicles that had
bile salts added) of the fluorescence (Fig. 4E) due to
residual Na+/H+ antiport activity of MdtM at the slightly
alkaline pH (Holdsworth and Law, 2013). Therefore, the
results of the acridine orange fluorescence quench/
dequench assays clearly supported an MdtM-dependent
bile salt/H+ antiport driven by the transmembrane electro-
chemical gradient.
MdtM-catalysed bile salt/H+ antiport is electrogenic
To determine whether MdtM catalyses electrogenic trans-
port by utilizing the transmembrane electrical potential
(Δψ) as the driving force, inverted vesicles were produced
from TO114 cells transformed with pMdtM or pD22A and
assayed for electrogenicity in a chloride-free and
potassium-free buffer using the Δψ-sensitive fluorophore
Oxonol V. Addition of lactate to energize vesicles buffered
to pH 7.2 resulted in the generation of a respiratory Δψ, as
evidenced by a rapid quench of the Oxonol V fluores-
cence signal (Fig. 5). The addition of 2.5 mM cholate to
the inverted vesicles enriched with wild-type MdtM
resulted in a partial depolarization of Δψ, represented as a
dequenching of the Oxonol V fluorescence, as the Δψ was
consumed by the MdtM-mediated bile salt/H+ transport
reaction (Fig. 5A). A similar response was detected upon
the addition of 2.0 mM deoxycholate to wild-type MdtM-
containing vesicles (Fig. 5C). In each of the assays, addi-
tion of the protonophore CCCP at the time indicated
resulted in almost complete dissipation of Δψ. Addition of
cholate to negative control vesicles enriched with dys-
functional MdtM D22A resulted in a perceptible dequench
(Fig. 5B), probably arising from residual electrogenic
Na+/H+ antiport activity of MdtM (Holdsworth and Law,
2013). In contrast, addition of the sodium salt of deoxy-
cholate to negative control vesicles resulted in no detect-
able depolarization of the transmembrane potential
(Fig. 5D). In this instance, the lack of any dequench signal
was probably due to the fact that MdtM possesses low
affinity for Na+ cations (Holdsworth and Law, 2013), and
the 2.0 mM concentration of Na+ cations in the assay was
insufficient to elicit any measureable electrogenic trans-
port. The results of assays performed at pH 6.0 (Fig. S6)
were similar to those observed for assays performed at
pH 7.2, except that addition of cholate to negative control
vesicles enriched with dysfunctional MdtM D22A mutant
resulted in no detectable depolarization (Fig. S6B).
Although the set of experiments described above
showed that MdtM-dependent antiport was Δψ-
consuming, from which it was inferred to be electrogenic,
to provide assurance that it was bile salt/H+ antiport and
not Na+/H+ antiport activity that was being measured,
additional control experiments were performed to test the
effects of adding sodium gluconate in place of the bile
salts, and by adding the ionophores nigericin (to selec-
tively dissipate ΔpH) and valinomycin (to selectively dis-
sipate Δψ) to inverted vesicles that overproduced wild-
type MdtM (Fig. S7). As shown in Fig. S7C, no response
of the Oxonol V fluorescence signal was observed upon
addition of 2.5 mM sodium gluconate to the vesicles at
pH 6.0. However, as expected, due to the electrogenic
Na+/H+ antiport activity of MdtM at alkaline pH (Holdsworth
and Law, 2013), a small dissipation of Δψ was recorded in
Fig. 5. Electrogenicity of MdtM-catalysed bile salt/H+ antiport.
Electrogenicity of MdtM-catalysed bile salt/H+ antiport at pH 7.2 as
probed by Oxonol V fluorometry of inverted vesicles of E. coli
TO114 cells transformed with pMdtM (left-hand traces) or, as a
negative control, pD22A (right-hand traces). Respiration-dependent
formation of Δψ was initiated by addition of 2 mM lactate at the
time indicated and antiport was initiated by addition of sodium
cholate (A and B) or sodium deoxycholate (C and D) at final
concentrations of 2.5 mM and 2 mM, respectively, at the time
indicated. Vesicles were depolarized by addition of CCCP to
100 μM.
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the assay performed at pH 7.2 (Fig. S7A). Addition of
valinomycin to abolish the Δψ (Fig. S7A), or the protono-
phore CCCP to abolish both components of the electro-
chemical gradient (Fig. S7C) to the vesicles at the times
indicated caused a rapid and complete dequench of the
Oxonol V fluorescence. In a final set of controls, nigericin
was added to inverted, wild-type MdtM-containing vesi-
cles pre-incubated with 50 mM potassium gluconate
(Fig. S7B and D). In the assay performed at pH 7.2 addi-
tion of the ionophore resulted in a small increase in the
magnitude of Δψ (observed on the assay trace in Fig. S7B
as a further quench in the Oxonol V fluorescence signal)
as ΔpH was converted to Δψ by the electroneutral K+/H+
exchange activity of the ionophore (Padan et al., 2005).
However, in the same assay performed at pH 6.0
(Fig. S7D) no such conversion was observed, probably
due to activity of other transporters that could maintain the
ΔpH in the more acidic environment. As observed in the
previous assays, valinomycin or CCCP caused a com-
plete dissipation of Δψ. All the control experiments pro-
vided evidence that the vesicles had retained integrity and
were therefore able to maintain an electrochemical poten-
tial across the membrane during the assay lifetime, and
also established that the nature of MdtM-catalysed
cholate/H+ and deoxycholate/H+ antiport is electrogenic.
Discussion
Consistent with a prior hypothesis that a significant part of
bile salt efflux is performed by a membrane transporter
system(s) other than AcrAB–TolC and EmrAB–TolC
(Thanassi et al., 1997), the results presented here provide
evidence that the E. coli single-component MFS trans-
porter MdtM, originally characterized as a multidrug efflux
protein (Holdsworth and Law, 2012a,b), functions in this
role.
MIC measurements demonstrated that although not
essential for resistance of E. coli to cholate and deoxy-
cholate, MdtM does make a significant contribution to it
(Table 1). Transcript levels of mRNA encoding MdtM,
however, did not increase in response to cholate or
deoxycholate exposure; this was not unexpected since
other single-component transporters that function physi-
ologically in bile salt efflux in other enteric bacterial
species are not upregulated at the level of mRNA in
response to bile challenge (Bron et al., 2006; Whitehead
et al., 2008; Hernandez et al., 2012).
The notion that MdtM plays a substantial role in bile salt
resistance in E. coli was reinforced by IC50 measurements
made at two physiologically relevant pH values (Fig. 1).
These measurements clearly showed that complementa-
tion of the ΔmdtM mutant with plasmidic DNA (pMdtM)
encoding wild-type MdtM under control of an arabinose-
inducible promoter recovered a bile salt-resistant pheno-
type. The calculated IC50 values also revealed that, at
pH 7.2, wild-type E. coli was significantly less tolerant of
deoxycholate than of cholate, an observation consistent
with the hydrophobicity of the bile salts tested, which is
higher for deoxycholate than for cholate, and hence,
reflects the capacity of each compound to permeate the
phospholipid membrane and enter the cell cytoplasm
(Heuman et al., 1989; Kamp et al., 1993). In contrast, at
the more acidic pH of 6.0, there was no significant differ-
ence in susceptibility to the two different bile salts;
however, at this pH the IC50 for cholate was only about
60% of that measured at pH 7.2. These observations can
be rationalized if consideration is given to the ionization
state of the bile salts at each pH. Cholate and deoxycho-
late are weak acids with pKa values of 6.4 and 6.6 respec-
tively (Budavari, 1996; Yokota et al., 2000). Therefore, at
pH 7.2, both would exist in predominantly anionic form,
with only ∼ 13% of the deoxycholate and ∼ 20% of the
cholate in an undissociated, lipophilic form that can
diffuse more easily across the membrane bilayer. At
pH 6.0, the prevalence of the protonated, electroneutral
state of each bile salt means that more molecules are in a
form that can readily enter the cell cytoplasm where they
can build up to potentially cytotoxic concentrations.
Although this may explain the approximately twofold dif-
ference between the IC50 values for cholate measured at
pH 7.2 and pH 6.0, it does not explain the lack of a similar
apparent decrease in resistance towards deoxycholate.
This may be a consequence of the more efficient parti-
tioning of deoxycholate into the cell cytoplasm, which
means that at pH 7.2 the machinery that comprises the
bile salt ‘effluxome’ is already saturated. An alternative
explanation could lie in the pH dependence of substrate
binding to the transporter protein(s) involved in cholate
and deoxycholate efflux due to different ionization state(s)
of the substrate binding site(s) at each pH, or the speci-
ficity of the same protein(s) for different charged states of
the bile salt cargo.
Substrate binding studies that exploited intrinsic trypto-
phan fluorescence of purified MdtM protein in detergent
solution established that both bile salts tested bound to
purified MdtM with micromolar affinity (Fig. 3), an obser-
vation in agreement with the transporter functioning as a
high-affinity bile salt efflux protein. The lower apparent
affinity (Kdapp) of MdtM for deoxycholate compared to
cholate may help explain the results of the IC50 assays
described above; the less efficient binding by MdtM of
deoxycholate that has diffused into the cytoplasm would
make the cells more susceptible to the cytotoxic effects of
this particular bile salt. Furthermore, the affinity of each
bile salt for MdtM displayed a striking pH-dependence that
resulted in reduced binding at lower pH. Analysis of the
circular dichroism spectra of MdtM at pH 6.0 and pH 7.2
confirmed that the reduced affinity for each substrate at
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the acidic pH did not arise due loss of structural integrity
of the DDM-solubilized transporter. Instead, the reduced
affinity at acidic pH suggests that a change in the proto-
nation state of individual amino acid side-chains that are
important for MdtM function affects substrate binding; just
such a competition for binding between protons and anti-
microbial substrate has been demonstrated in another
MFS drug/proton antiporter, MdfA, a close E. coli homo-
logue of MdtM (Fluman et al., 2012).
Single-component, secondary active multidrug antiport-
ers like MdtM cannot efflux antimicrobials completely out
of the bacterial cell; they can only catalyse their transport
from the cytoplasm into the periplasmic space. In the
absence of an additional efflux system capable of cata-
lysing transport from the periplasm into the extracellular
environment, the cytotoxins would simply build up in the
periplasmic space and leak back into the cytoplasm. Evi-
dence suggests that the single-component multidrug/
proton antiporters do not act unilaterally (Lee et al., 2000),
and that a functional synergism between them and tripar-
tite transporters such as AcrAB–TolC exists to confer
levels of resistance to antimicrobials that would otherwise
not be achievable. Indeed, it has been shown before that
both MdtM and MdfA interact synergistically with a tripar-
tite efflux system(s), most probably AcrAB–TolC, to
provide E. coli with an enhanced efflux activity to rid
the cell of antimicrobials (Tal and Schuldiner, 2009;
Holdsworth and Law, 2012a,b). Comparison of IC50 meas-
urements for cholate and deoxycholate made on the acrB
chromosomal deletion mutant that expressed dysfunc-
tional MdtM, and on the ΔacrB mutant complemented with
pMdtM, suggested just such synergism exists between
MdtM and AcrAB–TolC for efflux of bile salts. MdtM and
AcrAB–TolC appear to operate in series – and therefore
their effect on resistance is multiplicative – to provide an
effective mechanism of flushing bile salts completely out
of the cell. Disruption of one part of this dual-stage efflux
system increases the susceptibility of E. coli to antimicro-
bials, with hypersensitivity especially evident upon dys-
function of the tripartite efflux system. This dual-stage
efflux likely represents a general mechanism for multidrug
resistance in bacteria.
Although most characterized, substrate-specific sec-
ondary active transporters catalyse only one or other of
electrogenic or electroneutral transport, the ability of
their multidrug efflux counterparts to transport substrates
of different charges means that secondary active multi-
drug transporters possess capacity to catalyse both
types of electrically distinct transport reaction (Lewinson
et al., 2003). In the case of bile salt efflux, the electro-
genicity of the MdtM-mediated transport reaction raises
interesting questions as to the electronic nature of the
transported substrate and the stoichiometry of antiport.
At the relatively alkaline pH of between 7.4 and 7.8 that
exists in the E. coli cell cytoplasm (Padan et al., 1976)
about 90% of the cholate and deoxycholate molecules
present in this environment would exist in anionic form.
Therefore, in order to be transported across the inner
membrane in a neutral form, they must be associated
either with a proton or with a monovalent cation such as
Na+. Although the assays described here do not permit
an analysis of the stoichiometry of MdtM-catalysed bile
salt/H+ antiport, we favour a scenario whereby one
proton is exchanged for one cholate or deoxycholate
molecule.
The bile salt efflux role of MdtM highlights the extraor-
dinary capacity of single-component multidrug transport-
ers of the MFS to function in a diversity of physiologically
relevant roles. It is probable that the physiological roles of
MFS multidrug transporters contribute to their conserva-
tion in bacterial genomes and, consequently, the spread
of multidrug resistance. Notably, the capacity of these
proteins to function effectively in the disparate and harsh
environments encountered in the human gastrointestinal
tract provides a clue as to why E. coli and other Gram-
negative bacterial infections are challenging to treat with
currently available antibiotics.
Experimental procedures
All growth media, antibiotics and chemicals were purchased
from Sigma-Aldrich (Poole, Dorset, UK) unless stated
otherwise.
Bacterial strains and plasmids
Escherichia coli BW25113 {rrnB3 ΔlacZ4787 hsdR514
Δ(araBAD)567 Δ(rhaBAD)568 rph-1} (Datsenko and Wanner,
2000) and its ΔmdtM, ΔacrB, ΔemrB and ΔompF single-
deletion mutants were obtained from the Keio collection
(National BioResource Project, Japan) (Baba et al., 2006)
and used for MIC assays. The ΔmdtM and ΔacrB deletion
mutants were used as the background strains for determining
IC50 values of cells expressing wild-type mdtM (pMdtM) or, as
a control, dysfunctional MdtM D22A (pD22A) mutant from
pBAD/Myc-His A vector (Life Technologies, Paisley, UK)
(Holdsworth and Law, 2012a). Ethidium bromide efflux
assays used the outer membrane permeability mutant UTL2
strain of E. coli (Beja and Bibi, 1996). For production of
inverted vesicles used in transport assays, E. coli TO114
complemented with pMdtM or pD22A was used. The TO114
strain is deficient in the Na+/H+ antiporters NhaA and NhaB,
and the K+/H+ antiporter ChaA. This strain was chosen spe-
cifically to abrogate any potential interference from NhaA and
NhaB Na+/H+ antiport activity (Holdsworth and Law, 2013).
Overproduction of wild-type and mutant MdtM for purification
and subsequent use in substrate-binding assays was per-
formed in E. coli LMG194 (KS272 Δara714 leu::Tn10) trans-
formed with the appropriate plasmid (Holdsworth and Law,
2012a).
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Construction of MdtM mutants
MdtM W309F and W309A mutants were produced using the
QuikChange Lightning site-directed mutagenesis kit (Agilent
Technologies) with pMdtM as the template, and the following
5′–3′ PCR primers (W309F forward: tcgccgcacgtcttcctgt
ggtcggtgc; W309F reverse: gcaccgaccacaggaagacgtgcg
gcga; W309A forward: gtcgccgcacgtcgcgctgtggtcggtg;
W309A reverse: caccgaccacagcgcgacgtgcggcgac). The fidel-
ity of each mutant construct was verified by DNA sequence
analysis.
Determination of MIC of bile salts
MICs of the sodium salts of cholate and deoxycholate were
determined using serial twofold dilutions of each bile salt from
a 128 mg ml−1 stock on solid Luria–Bertani (LB) agar plates,
each inoculated with 104 colony-forming units (cfu) of the
strain to be tested. The plates were incubated overnight at
37°C prior to ocular inspection for colony growth.
Quantitative PCR analysis of mdtM transcript levels
To test for the effects of bile salt on transcript levels of MdtM,
total RNA was extracted from cell pellets prepared from dupli-
cate 1 ml samples of mid-log phase, wild-type E. coli
BW25113 with or without 20 mM sodium cholate, and taken
at t = 0 min, t = 15 min and t = 30 min. RNA (1 μg) was
treated with DNase (Turbo DNA Free, Life Technologies)
before reverse-transcription to cDNA. Transcriptional
changes in mdtM between cholate-treated and untreated
samples were assessed using real-time quantitative PCR
analysis of these cDNAs, with changes expressed relative to
a reference transcript (rrsB, 16S rRNA). PCR primers were
designed against GenBank-derived rrsB and mdtM
sequences (rrsB forward: agagcaagcggacctcataa; rrsB
reverse: aacgtattcaccgtggcatt; mdtM forward: gcctgggatcat-
taatgtgg; mdtM reverse: agccactgtaacgccatacc). Following
collection of Ct and efficiency values using RotorGene soft-
ware, transcriptional changes in mdtM were determined
using the Augmented ΔΔCt method (Pfaffl, 2001).
Determination of IC50 of cholate and deoxycholate
To test the contribution of MdtM to intrinsic resistance against
bile salts, growth of E. coli cells was measured in LB liquid
medium that contained varying concentrations of the sodium
salts of cholate or deoxycholate at pH values of 7.2 and 6.0.
The pH of the medium was buffered by 70 mM 1,3-
bis[tris(hydroxymethyl)-methylamino] propane (BTP) and pH
was adjusted by HCl. Assays were performed based on a
previously described method (Holdsworth and Law, 2012b).
Whole-cell ethidium bromide transport assays
The effect of addition of 3.0 mM sodium cholate and 3.0 mM
sodium deoxycholate on ethidium bromide (EtBr) efflux by
E. coli outer membrane permeability mutant UTL2 cells
enriched with MdtM was determined using a method
described before (Holdsworth and Law, 2013) except that
assays were performed at pH 6.0 to abrogate interference by
MdtM-catalysed Na+(K+)/H+ antiport that occurs at alkaline
pH. To test that bile salt had not compromised cell membrane
integrity, UTL2 cells used to investigate the inhibitory effects
of 3.0 mM sodium cholate on the EtBr efflux activity of MdtM
were removed from the cuvette, washed twice in assay buffer
to remove CCCP, then re-energized by addition of glucose.
Measurement of proton-driven antiport
Assays of bile salt/H+ antiport were conducted by measuring
the fluorescence quenching/dequenching of the pH-sensitive
indicator acridine orange upon addition of either 2.5 mM
cholate or 2.0 mM deoxycholate to energized inverted mem-
brane vesicles generated from antiporter-deficient E. coli
TO114 cells that overproduced recombinant wild-type MdtM.
Inverted vesicles of TO114 cells that overproduced dysfunc-
tional MdtM from pD22A were used as controls. Transport
measurements were performed as described before
(Holdsworth and Law, 2012b) at pH values of 7.2 and 6.0.
Control experiments to ensure any observed fluorescence
dequench was not a result of MdtM-mediated Na+/H+ antiport
were performed by addition of 2.5 mM sodium gluconate
instead of bile salt. All experiments were performed in tripli-
cate on at least two separate preparations of inverted
vesicles.
Measurement of the electrogenicity of bile
salt/H+ antiport
The Δψ-sensitive fluorophore Oxonol V [bis-(3-phenyl-5-
oxoisoxazol-4-yl)pentamethine oxonol] (Cambridge Biosci-
ence, Cambridge, UK) was used to determine if the MdtM-
mediated antiport observed in the previous experiments was
electrogenic. Inverted vesicles were produced from TO114
cells transformed with pMdtM or pD22A as described previ-
ously (Holdsworth and Law, 2013), except that the vesicle
resuspension buffer was made Cl−-free by substitution of the
140 mM choline chloride component with 280 mM sorbitol
and by using H2SO4 rather than HCl to adjust buffer pH.
Vesicles (0.5 mg ml−1 membrane protein) were added to
assay buffer (10 mM BTP, 5 mM MgSO4, 5 μM Oxonol V) that
had its pH adjusted to 7.2 or 6.0. Electrogenic antiport activity
was estimated on the basis of its ability to dissipate the
established Δψ (recorded as a dequenching of the fluores-
cence signal) in response to addition of 2.5 mM sodium
cholate or 2.0 mM sodium deoxycholate to vesicles at the
times indicated. As a control experiment, to ensure that there
was no interference from MdtM-mediated Na+/H+ antiport,
2.5 mM sodium gluconate was substituted for bile salt. As a
further control, 1 μM of the ionophore nigericin (which at low
concentrations selectively consumes ΔpH in the presence of
K+ via electroneutral K+/H+ exchange) was added to vesicles
of TO114 cells transformed with pMdtM. These vesicles were
incubated in assay buffer that contained 50 mM K+ gluconate,
and valinomycin (5 μM) was added to selectively abolish Δψ.
Purification of MdtM
Wild-type and mutant protein for use in substrate binding
assays and circular dichroism (CD) spectroscopy studies was
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homologously overexpressed in E. coli LMG194 cells and
purified following the protocol described previously
(Holdsworth and Law, 2012a). Purified protein was placed on
ice and used immediately for substrate binding studies. Con-
centrated MdtM solution for use in CD studies was diluted
down with an imidazole- and NaCl-free buffer to minimize
interference from those compounds with the spectroscopic
measurements.
Substrate binding assays
Substrate-binding affinity of purified, wild-type MdtM for the
sodium salts of cholate and deoxycholate was determined at
pH 7.2 and pH 6.0 using intrinsic tryptophan fluorescence
quenching of protein in detergent solution based on the pro-
tocol described previously (Holdsworth and Law, 2012b).
Control assays that investigated binding of cholate to the
W309F and W309A MdtM mutants were performed at pH 7.2.
Circular dichroism (CD) spectroscopy
Far UV circular dichroism spectra were recorded using a
JASCO J-810 spectropolarimeter (Jasco UK). MdtM samples
were analysed at pH 6 and pH 7.2 using a 5.3 μM protein
solution in a 0.02 cm pathlength quartz cuvette. A suitable
buffer baseline was collected and subtracted from each
protein spectrum. Corrected data were expressed in terms of
mean residue ellipticity (degrees cm−2 dmol−1). The online CD
secondary structure analysis server Dichroweb (Whitmore
and Wallace, 2004) and the CONTIN procedure Reference
set 4 (Provencher and Glockner, 1981) was used to analyse
the CD data.
Western blot analysis of recombinant MdtM
Estimation of expression levels of recombinant wild-type and
D22A mutant MdtM in transformed BW25113 ΔmdtM and
BW25113 ΔacrB cells grown at pH 7.2 and pH 6.0 was per-
formed by Western blot analysis following a protocol
described before (Holdsworth and Law, 2013).
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